STAT

STAT+: Pharmalittle: Biden wins biotech support despite his policies; WHO sets Covid-19 compensation fund for low-income nations

From a policy perspective, Joe Biden should be biotech’s worst nightmare. But that isn’t stopping major biotech chief executives and investors from personally backing Biden's campaign.
Source: Alex Hogan/STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall,, and catch up on our reading. And what about you? This may be your last chance to mail in your ballot. You could boost the economy by shopping for winter wear. Or wish upon a star and make the pandemic go away (wouldn’t that be nice?). Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da STAT

STAT1 min lettiMedical
STAT+: Pharmalittle: An Arthritis Drug Reduced Covid-19 Death Rates; Impatience Grows Over Choosing FDA Commissioner
Tocilizumab, a drug usually used to treat rheumatoid arthritis, reduced the rate of death in hospitalized Covid-19 patients in a major clinical trial.
STAT1 min lettiMedical
STAT+: Pharmalittle: Pause For J&J Covid-19 Shot To Continue At Least A Week; Biden Expands Candidate List For FDA Commish
The U.S. government pause on use of the Johnson & Johnson Covid-19 vaccine is unlikely to be lifted for at least another week or 10 days.
STAT1 min lettiMedical
STAT+: Pharmalittle: FDA Panel Endorses Moderna Covid-19 Vaccine; Sacklers Dodge Blame For Opioid Crisis At Hearing
An FDA advisory panel recommended the agency issue an emergency use authorization for the Moderna Covid-19 vaccine, all but guaranteeing the agency will do so.